Savanna Biotherapeutics, Inc.
Biotechnology company · Aliso Viejo, California, United States
Savanna Biotherapeutics, Inc. is a biotechnology company headquartered in Aliso Viejo, California, United States. Its earliest recorded incorporation is in 2020. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $2.3 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2025.
Savanna Biotherapeutics at a glance
What does Savanna Biotherapeutics do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $2.3 million in total (2021 to 2025). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $13 million sold (2025).
Frequently asked questions about Savanna Biotherapeutics
Where is Savanna Biotherapeutics headquartered?
Savanna Biotherapeutics, Inc. is headquartered in Aliso Viejo, California, United States.
What does Savanna Biotherapeutics do?
Savanna Biotherapeutics, Inc. is a biotechnology company.
When was Savanna Biotherapeutics founded?
The earliest incorporation on record for Savanna Biotherapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- Aquesys IncAliso Viejo, California, United States
- Neuros Medical, Inc.Aliso Viejo, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences